These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12915889

  • 1. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.
    Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C.
    Br J Cancer; 2003 Aug 18; 89(4):746-53. PubMed ID: 12915889
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 3. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 4. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
    Iglesias-Gato D, Zheng S, Flanagan JN, Jiang L, Kittaka A, Sakaki T, Yamamoto K, Itoh T, Lebrasseur NK, Norstedt G, Chen TC.
    J Steroid Biochem Mol Biol; 2011 Nov 15; 127(3-5):269-75. PubMed ID: 21911059
    [Abstract] [Full Text] [Related]

  • 5. The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression.
    Shany S, Levy Y, Lahav-Cohen M.
    Steroids; 2001 Nov 15; 66(3-5):319-25. PubMed ID: 11179740
    [Abstract] [Full Text] [Related]

  • 6. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N, Persons KS, Chen TC, Ray R.
    J Cell Biochem; 2003 Aug 01; 89(5):909-16. PubMed ID: 12874825
    [Abstract] [Full Text] [Related]

  • 7. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1997 Aug 01; 138(8):3290-8. PubMed ID: 9231780
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 9. 1α,25-Dihydroxyvitamin D3 synergistically enhances anticancer effects of ginsenoside Rh2 in human prostate cancer cells.
    Ben-Eltriki M, Deb S, Guns EST.
    J Steroid Biochem Mol Biol; 2021 May 15; 209():105828. PubMed ID: 33493594
    [Abstract] [Full Text] [Related]

  • 10. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
    Ly LH, Zhao XY, Holloway L, Feldman D.
    Endocrinology; 1999 May 15; 140(5):2071-6. PubMed ID: 10218956
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC, Holick MF, Lokeshwar BL, Burnstein KL, Schwartz GG.
    Recent Results Cancer Res; 2003 May 15; 164():273-88. PubMed ID: 12899529
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    Qiao S, Pennanen P, Nazarova N, Lou YR, Tuohimaa P.
    J Steroid Biochem Mol Biol; 2003 May 15; 85(1):1-8. PubMed ID: 12798352
    [Abstract] [Full Text] [Related]

  • 13. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Moffatt KA, Johannes WU, Miller GJ.
    Clin Cancer Res; 1999 Mar 15; 5(3):695-703. PubMed ID: 10100724
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH, Burnstein KL.
    Endocrinology; 1998 Mar 15; 139(3):1197-207. PubMed ID: 9492054
    [Abstract] [Full Text] [Related]

  • 15. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Mar 15; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R.
    Clin Cancer Res; 2004 Dec 01; 10(23):8018-27. PubMed ID: 15585637
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 18. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.
    Rohan JN, Weigel NL.
    Endocrinology; 2009 May 17; 150(5):2046-54. PubMed ID: 19164469
    [Abstract] [Full Text] [Related]

  • 19. A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cells.
    Gavrilov V, Leibovich Y, Ariad S, Lavrenkov K, Shany S.
    J Steroid Biochem Mol Biol; 2010 Jul 17; 121(1-2):391-4. PubMed ID: 20214985
    [Abstract] [Full Text] [Related]

  • 20. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1999 Mar 17; 140(3):1205-12. PubMed ID: 10067845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.